Paul Andrew Mazar - Chief Scientific Officer, Monopar Therapeutics

As of October 1, 2021


Paul Andrew Mazar Net Worth

  • Net worth is estimated to be at least $3.22M
  • Owns at least 4,277,940 units of Monopar Therapeutics stock
  • Sold an estimated value of $1.84M in the last 2 years at Monopar Therapeutics

Paul Andrew Mazar Trading

  • Largest purchase of shares was 125,000 units , worth over $1M on December 20, 2019
  • Largest sale of shares was 125,000 units , worth over $1.83M on February 16, 2021
  • In total has made about 7 transactions over 2 years
  • Usually trades in February and January, with the busiest year in 2021
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Paul Andrew Mazar Mailing Address

  • Mailing address is 1000 Skokie Blvd Suite 350 Wilmette IL 60091 IL

Monopar Therapeutics Insider Trading

  • The most recent transaction was 125,000 units sold on February 16, 2021 by Tactic Pharma Llc, Paul Andrew Mazar, Chandler Robinson, Thomas Ohalloran V and Michael Brown worth over $1.83M
  • In the last 2 years, insiders at Monopar Therapeutics sold an estimated value of $1.89M and bought an estimated value of $6.01M
  • The most active traders are Michael Brown,  Arthur Klausner,  and Christopher Starr
  • Insider trading is most common in January, with the busiest year in 2021

Monopar Therapeutics Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1